6 nominees · 5 ballot items.
Elect six directors; advisory approval of named executive officer compensation (say-on-pay); approve Second Amended and Restated 2019 Performance Incentive Plan to increase shares available for grants; ratify Grant Thornton LLP as independent auditors for fiscal 2026; and advisory vote on frequency of future say-on-pay votes (board recommends annual).
Elect the six director nominees named in the Proxy Statement to serve until the 2027 annual meeting and until their successors are elected and qualified.
Advisory approval of the compensation of the Company's named executive officers as disclosed in the Proxy Statement (non-binding).
This non-binding management proposal asks shareholders to approve the Company’s disclosure of named executive officer (NEO) compensation as presented in the Proxy Statement, effectively endorsing the structure and amounts of pay awarded to the Company’s top executives. Management seeks this advisory vote to validate its mix of fixed pay, annual performance bonuses tied to Adjusted EBITDA, margin and sales, and longer-term cash- and equity-based incentives that emphasize retention and alignment with long-term shareholder value. The Company positions a substantial portion of pay as performance‑based, with multi-year cash LTIP awards and performance‑based RSUs that vest only if pre-specified financial and operational targets are achieved, reflecting a pay-for-performance philosophy. The Board’s recommendation of “FOR” rests on recent stockholder engagement results (including high prior-year say-on-pay support), benchmarking by independent compensation consultants and the Compensation Committee’s view that existing programs balance competitiveness with accountability. Potential governance considerations include the Company’s status as a smaller reporting company (permitted reduced disclosure), the recent management transition and material restructuring that make retention-focused awards more salient, and clawback and minimum vesting provisions intended to protect shareholders. While the vote is advisory and does not change contractual terms, its outcome is used by the Compensation Committee to inform future pay decisions; a negative result would likely trigger additional shareholder outreach and potential program changes. Given the Company’s disclosure of performance metrics, recent limited payout outcomes (demonstrating alignment) and explicit stockholder engagement, the Board argues that approval supports continuity in executive incentive design during a pivotal turnaround period. Investors evaluating this proposal should weigh the strength of disclosed performance metrics, vesting terms, historical say-on-pay support, and potential dilution from equity awards against the Company’s need to retain executive talent during its transformation.
Approve the Second Amended and Restated 2019 Performance Incentive Plan (the “Second Amended 2019 Plan”), including increasing the number of shares available for grant and extending the plan term.
This management proposal asks shareholders to approve a second amendment and restatement of the Company’s Amended and Restated 2019 Performance Incentive Plan to increase the share reserve (an incremental 1.928 million shares) and extend the plan term. Management seeks shareholder approval because the existing reserve is projected to last less than two years at current grant levels and the Company is in a period of active transformation with new executives whose retention the Board believes requires competitive equity incentives. The proposal is contextualized by prior stockholder approval history (2019 original plan and 2024 amendment), recent stockholder outreach where investors acknowledged the importance of equity for alignment and considered the anticipated dilution acceptable, and by the Company’s stated improvements in operations and early signs of stabilization. The plan includes investor-protective features that management highlights: no evergreen provision, anti-repricing provisions, a one-year minimum vesting requirement (with limited exceptions), director compensation caps, clawback provisions, and conservative share-counting rules for options/SARs after February 3, 2024. The Board’s recommendation of “FOR” is premised on the need to maintain adequate equity capacity to attract and retain key talent and to align management incentives with long-term shareholder returns during the turnaround. From a governance perspective, investors should weigh the proposed incremental dilution and historical burn rate (around 3.5% annually) against the Company’s need to restore and grow performance and retain leadership. If approved, the amendment substantially increases the available shares for grants but retains several guardrails intended to limit dilution and protect shareholders, while preserving administrative flexibility for the Compensation Committee. For sophisticated investors, relevant follow-ups would include modeling potential dilution scenarios under differing performance outcomes, reviewing past grant sizes and timing (particularly near management transitions), and monitoring post-approval grant pacing and disclosure to ensure the share usage and vesting outcomes align with promised retention and performance objectives.
Ratify the appointment of Grant Thornton LLP as the Company's independent registered public accounting firm for fiscal year 2026.
Advisory vote to indicate shareholder preference for how often the Company should hold future advisory votes on named executive officer compensation (choices: 1, 2 or 3 years).
This non-binding management proposal asks shareholders to indicate whether the Company should hold advisory votes on executive compensation every one, two, or three years. The Board recommends an annual (1-year) frequency, reasoning that annual votes provide more regular shareholder feedback on pay practices and align with the Company’s ongoing shareholder engagement and evolving turnaround efforts. The advisory nature of the vote means the Board retains discretion, but it will consider the plurality outcome when setting its policy; if no option receives a majority, the Board will consider the option receiving the most votes as the preferred frequency. For investors, the core trade-off is between more frequent accountability (annual votes) and reducing administrative burden or short-termism (multi-year votes). Given the Company’s recent management changes and active compensation adjustments tied to performance metrics, management argues that annual votes are appropriate to ensure timely investor input. The Board also notes it will consider results and investor feedback to determine future practice, so the vote functions as a governance signal rather than a binding mandate. Analysts evaluating governance should consider this recommendation alongside past say-on-pay outcomes and the Company’s communication and responsiveness to shareholder concerns.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | FMR LLC | 14.8% | 5,771,796 | $8M |
| 2 | Union Square Park Capital Management, LLC | 6.7% | 2,600,802 | $4M |
| 3 | JB CAPITAL PARTNERS LP | 4.4% | 1,710,794 | $2M |
| 4 | Archon Capital Management LLC | 4.3% | 1,668,905 | $2M |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 4.0% | 1,543,413 | $2M |
| 6 | GABELLI FUNDS LLC | 3.1% | 1,199,501 | $2M |
| 7 | GAMCO INVESTORS, INC. ET AL | 1.8% | 712,500 | $1M |
| 8 | DIMENSIONAL FUND ADVISORS LP | 1.7% | 666,516 | $940K |
| 9 | Skylands Capital, LLC | 1.6% | 639,800 | $902K |
| 10 | GABELLI Co INVESTMENT ADVISERS, INC. | 1.6% | 635,980 | $897K |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.